Literature DB >> 8852915

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media.

W A Craig1, D Andes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8852915     DOI： 10.1097/00006454-199603000-00015

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  92 in total

1.  Influence of Pharmacokinetic and Pharmacodynamic Principles on Antibiotic Selection.

Authors:  George G. Zhanel
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

2.  Assumed versus approved breakpoints.

Authors:  D A Preston; M R Turnak
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Current Concepts of Therapy for Otitis Media.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

4.  Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens.

Authors:  G H Ross; L B Hovde; K H Ibrahim; Y H Ibrahim; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 5.  Management of acute otitis media in the 1990s: the decade of resistant pneumococcus.

Authors:  S L Block
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

Review 6.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Authors:  S J Schrag; B Beall; S F Dowell
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

7.  Streptococcus pneumoniae: Activity of Newer Agents Against Penicillin-Resistant Strains.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

Review 8.  In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis.

Authors:  David Andes
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

9.  In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model.

Authors:  D Andes; K Marchillo; J Lowther; A Bryskier; T Stamstad; R Conklin
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.

Authors:  Cornelia B Landersdorfer; Carl M J Kirkpatrick; Martina Kinzig-Schippers; Jürgen B Bulitta; Ulrike Holzgrabe; George L Drusano; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.